Company intelligence / Profile preview

Lacorium Health

Ownership: Private
Development stage: Other

Overview

Lacorium Health is a biotechnology company developing engineered live biotherapeutic products (LBPs) for the treatment of inflammatory bowel diseases. The company's platform utilizes engineered Lactobacillus strains to deliver therapeutic proteins directly to the gastrointestinal mucosa, aiming to provide high local concentrations of medicine while reducing systemic exposure. This approach seeks to improve the safety and efficacy profile of biologics used in treating conditions like Ulcerative Colitis. Lacorium was spun out of the Technical University of Denmark and is supported by the BioInnovation Institute.

Therapeutic areas: Gastroenterology
Modalities: Live biotherapeutic product therapyMicrobial therapyProtein
Industry: Biotech

Drug pipeline

1 asset

AMYCOT

Unknown

Partnerships

BioInnovation Institute

Beyond the preview

Go deeper on Lacorium Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lacorium Health.

Explore the full profile